Farrag Tarik Y, Lin Frank R, Cummings Charles W, Koch Wayne M, Flint Paul W, Califano Joseph A, Broussard Jennifer, Bajaj Gopal, Tufano Ralph P
Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Laryngoscope. 2006 Oct;116(10):1864-6. doi: 10.1097/01.mlg.0000234917.08822.cd.
To determine a plan for the management of cervical lymph nodes in patients undergoing salvage laryngeal surgery (SLS) for recurrent/persistent laryngeal cancer after primary radiotherapy (RT).
: Retrospective chart review.
Charts of 51 consecutive patients who had salvage total or supracricoid laryngectomy with or without neck dissection for recurrent/persistent laryngeal squamous cell carcinoma after primary RT from 1988 to 2005 in our institution were reviewed. No patients received concomitant or neo-adjuvant chemotherapy. Thirty-four patients underwent SLS along with unilateral or bilateral neck dissection, whereas 17 patients underwent the SLS without neck dissection. Reports of preRT and preSLS staging of the primary tumor and the neck, recorded using the TNM system, were reviewed. Reports of the final histopathologic examination for the excised laryngeal cancer and cervical lymph nodes were reviewed.
Thirty-four patients underwent SLS with unilateral or bilateral neck dissection. The preRT staging of the primary tumor for those 34 patients showed that 32 (94%) were staged T-1 (14) and T-2 (18), whereas the preSLS staging of the primary tumor for those 34 patients showed that 29 (85%) were staged T-3 and T-4. The postSLS final histopathologic examination of the excised lymph nodes in those 34 patients demonstrated that 30 (88%) did not have any evidence of nodal metastasis. On comparing patients with and without nodal metastasis (on their postSLS final histopathology), we found that the preSLS neck staging, based on computed tomographic (CT) scanning of the neck, was significantly associated with the negative/positive postSLS status of nodal metastasis (P = .006). Of 29 patients staged preSLS as N-0, 28 (97%) patients did not have nodal metastasis on their postSLS final pathology (negative predictive value = 97%, confidence interval, 82.2-99.9). PreRT neck staging, preRT and preSLS staging of the primary tumor, along with laryngeal subsite involvement (supraglottis, glottis, subglottis) did not significantly correlate with the status of neck metastasis on final postSLS histopathology (P = .68, 0.78, 0.49, and 0.42, respectively). None of the 34 patients had any neck tumor recurrence in the postSLS follow-up period (median, 3 yr). In addition, all 17 patients who underwent SLS without neck dissection were staged N-0 both before RT as well as preSLS, and none developed neck disease in the postSLS follow-up period (median, 2.5 yr).
Management of the neck in patients undergoing salvage total or supracricoid laryngectomy for laryngeal cancer recurrence/persistence after primary RT should be based on the preSLS CT staging of the neck. Patients staged N-0 preSLS are not likely to harbor occult nodal metastasis and therefore may not require elective neck dissection.
为接受挽救性喉手术(SLS)治疗原发性放疗(RT)后复发/持续性喉癌的患者确定颈部淋巴结管理方案。
回顾性病历审查。
回顾了1988年至2005年在本机构接受原发性放疗后因复发/持续性喉鳞状细胞癌行挽救性全喉或环状软骨上喉切除术伴或不伴颈部清扫的51例连续患者的病历。所有患者均未接受同步或新辅助化疗。34例患者在接受SLS的同时进行了单侧或双侧颈部清扫,而17例患者接受了未行颈部清扫的SLS。回顾了使用TNM系统记录的原发性肿瘤和颈部放疗前及SLS前分期报告。回顾了切除的喉癌和颈部淋巴结的最终组织病理学检查报告。
34例患者接受了单侧或双侧颈部清扫的SLS。这34例患者的原发性肿瘤放疗前分期显示,32例(94%)为T-1(14例)和T-2(18例)期,而这34例患者的原发性肿瘤SLS前分期显示,29例(85%)为T-3和T-4期。这34例患者切除淋巴结的SLS后最终组织病理学检查显示,30例(88%)没有任何淋巴结转移的证据。在比较有或无淋巴结转移的患者(根据其SLS后最终组织病理学)时,我们发现基于颈部计算机断层扫描(CT)的SLS前颈部分期与SLS后淋巴结转移的阴性/阳性状态显著相关(P = 0.006)。在SLS前分期为N-0的29例患者中,28例(97%)在SLS后最终病理检查中没有淋巴结转移(阴性预测值 = 97%,置信区间,82.2 - 99.9)。放疗前颈部分期、原发性肿瘤放疗前和SLS前分期以及喉亚部位受累情况(声门上区、声门区、声门下区)与SLS后最终组织病理学检查时的颈部转移状态均无显著相关性(P分别为0.68、0.78、0.49和0.42)。34例患者在SLS后的随访期(中位时间,3年)内均未出现颈部肿瘤复发。此外,所有17例未行颈部清扫的SLS患者在放疗前及SLS前均分期为N-0,且在SLS后的随访期(中位时间,2.5年)内均未发生颈部疾病。
对于原发性放疗后因喉癌复发/持续性而行挽救性全喉或环状软骨上喉切除术的患者,颈部管理应基于SLS前颈部CT分期。SLS前分期为N-0的患者不太可能存在隐匿性淋巴结转移,因此可能不需要选择性颈部清扫。